MedImmune, Inc. · Gaithersburg, MD United States
Company Description
View MedImmune, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window MedImmune works to boost the immune systems of babies and grown-ups. Its flagship biotech product, Synagis, prevents respiratory syncytial virus (RSV), a major cause of pneumonia and other respiratory disease in infants and children. Also on the market are FluMist, its nasal spray flu vaccine, and Ethyol, which treats side effects of chemotherapy and radiation. The company is working on dozens of investigational therapies -- including monoclonal antibodies, vaccines, and small molecule drugs -- in the areas of infectious diseases, cancer, and inflammatory conditions. MedImmune is a subsidiary of UK-based pharmaceutical giant AstraZeneca . To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key MedImmune, Inc. Financials
| Company Type | Subsidiary Headquarters |
| Fiscal Year-End | December |
| Employees | 6,000 |
MedImmune, Inc. Executives
61 executives listed for MedImmune, Inc.'s Gaithersburg, MD location.
| Title | Name & Bio | Contact |
| President | Tony Zook | Network |
| EVP Operations | Bernardus Machielse | Network |
| SVP and CFO | Tim Pearson | Network |
Competition
Competitive Landscape for MedImmune, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top MedImmune, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!